Skip to search formSkip to main contentSkip to account menu

OSI-7904L

Known as: GS7904L, OSI 7904L, OSI-7904 liposomal 
A liposome-encapsulated formulation of the benzoquinazoline folate analog OSI-7904 with antineoplastic activity. As a thymidylate synthase inhibitor… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Cambio de cura tradicional a cura mölndal en una unidad de enfermería quirúrgica
espanolObjetivo: Comparar la “tecnica Molndal modificada” (Mo) frente a la “tecnica tradicional” (TR) para determinar la calidad… 
2009
2009
A phase II study of single agent OSI-7904L in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN).
e17005 Background: Given the limited efficacy and relative toxicity of chemotherapy for metastatic or recurrent squamous cell… 
2008
2008
Phase I, Pharmacokinetic and Biological Correlative Study of OSI-7904L, a Novel Liposomal Thymidylate Synthase Inhibitor, and Cisplatin in Patients with Solid Tumors
Purpose: To evaluate the safety and describe the pharmacokinetic profile of OSI-7904L, a novel liposomal thymidylate synthase… 
2008
2008
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer
PurposeOSI-7904L is a liposomal formulation of a potent thymidylate synthase (TS) inhibitor. This phase I study evaluated the… 
2007
2007
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers
SummaryThe prognosis of advanced biliary tract carcinoma is poor with chemotherapy limited to a palliative role. This randomised… 
Review
2006
Review
2006
Novel therapeutic developments other than EGFR and VEGF inhibition in colorectal cancer.
Developments that may improve existing cytotoxic therapy for colorectal cancer (CRC) include alternatives to 5-fluorouracil (5-FU… 
2005
2005
Phase II pharmacokinetic (PK) and pharmacodynamic (PD) study of OSI-7904L in previously untreated patients (pts) with advanced gastric or gastroesophageal junction cancer (G/GEJC)
4042 Background: OSI-7904L is a liposomal TS inhibitor with increased plasma residence and superior preclinical antitumor… 
1993
1993
[특집]고속 멀티미디어 통신을 위한 OSI 하위계층 표준화
1993
1993
「엑스포」및「고속 멀티미디어 통신을 위한 OSI 하위계층 표준화」특집을 내면서
1970
1970
Matematyczne uzasadnienie operacji wyznaczania osi fałdu z diagramu foliacji
MATHEMATICAL MOTIVE FOR DETERMINING FOLD AXIS FROM FOLIATION DIAGRAM Summary There are two equivalent methods of determining… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)